Avenue Therapeutics, Inc. Stock
Stocks
ATXI
US05360L4032
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3877 USD | +8.90% |
|
+40.67% | -43.00% |
| Market Cap | 1.28M 1.11M 1.03M 949K 1.79M 122M 1.82M 12.18M 4.78M 60.71M 4.8M 4.69M 204M | P/E 2024 |
-0.22x | P/E 2025 | -0.73x |
|---|---|---|---|---|---|
| Enterprise Value | -1.58M -1.37M -1.28M -1.17M -2.21M -151M -2.25M -15.05M -5.91M -74.97M -5.92M -5.79M -251M | EV / Sales 2024 |
-
| EV / Sales 2025 | -491,128x |
| Free-Float |
86.49% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +8.90% | ||
| 1 week | +40.67% | ||
| 1 month | +38.46% | ||
| 3 months | -29.51% | ||
| 6 months | +91.93% | ||
| Current year | -43.00% |
| 1 week | 0.29 |  | 0.4 |
| 1 month | 0.25 | | 0.4 |
| Current year | 0.15 | | 0.79 |
| 1 year | 0.15 | | 0.97 |
| 3 years | 0.15 | | 82.5 |
| 5 years | 0.15 | | 2,115 |
| 10 years | 0.15 | | 13,882.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 59 | 2022-07-31 | |
David Jin
CEO | Chief Executive Officer | 36 | 2022-03-30 |
Jaclyn Jaffe
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 71 | 2015-02-08 | |
Neil Herskowitz
BRD | Director/Board Member | 69 | 2015-07-31 |
Jay Kranzler
CHM | Chairman | 68 | 2023-03-06 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 1/2/26 | Free | Company | 111,209 | 3.4934% | ||
| 3/31/25 | Free | Company | 33,724 | 1.6419% | ||
| 12/31/24 | Other | Company | 294,800 | 15.4214% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +8.90% | +40.67% | -14.79% | -99.51% | 1.28M | |
| +2.35% | +2.74% | +33.41% | +79.20% | 56.54B | |
| -0.21% | -7.38% | +25.34% | +63.02% | 53.6B | |
| -2.44% | +1.40% | -15.74% | -16.80% | 22.91B | |
| -2.85% | -7.78% | -8.09% | +346.36% | 21.37B | |
| +2.49% | -0.92% | +20.31% | -12.15% | 20.27B | |
| +0.79% | -1.06% | +29.29% | -33.32% | 17.56B | |
| +0.58% | -5.88% | +16.30% | +540.37% | 14.75B | |
| -5.25% | -4.23% | +46.41% | +169.05% | 13.33B | |
| +3.41% | -6.61% | +163.08% | +280.43% | 13.53B | |
| Average | +0.78% | -3.41% | +29.55% | +131.66% | 23.39B | |
| Weighted average by Cap. | +0.23% | -2.96% | +28.67% | +119.98% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 1.4 1.22 1.14 1.04 1.97 134.03 2 13.39 5.26 66.72 5.27 5.16 223.74 |
| Net income | -11.65M -10.13M -9.43M -8.66M -16.35M -1.11B -16.6M -111M -43.62M -554M -43.76M -42.8M -1.86B | -2.91M -2.53M -2.35M -2.16M -4.08M -278M -4.14M -27.74M -10.89M -138M -10.93M -10.69M -464M |
| Net Debt | -2.59M -2.25M -2.1M -1.93M -3.64M -248M -3.7M -24.74M -9.71M -123M -9.74M -9.53M -413M | -2.86M -2.48M -2.31M -2.12M -4.01M -273M -4.07M -27.23M -10.69M -136M -10.72M -10.49M -455M |
Employees
1
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-30 | US$0.3877 | +8.90% | 6,543 |
| 26-07-29 | US$0.3560 | +18.67% | 9,620 |
| 26-07-28 | US$0.3000 | +4.63% | 20,674 |
| 26-07-27 | US$0.2867 | +4.02% | 370 |
| 26-07-24 | US$0.2756 | +6.01% | 112 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ATXI Stock
Select your edition
All financial news and data tailored to specific country editions
